Small molecules to the rescue: Inhibition of cytokine signaling in immune-mediated diseases

M Gadina, N Gazaniga, L Vian, Y Furumoto - Journal of autoimmunity, 2017 - Elsevier
Cytokines are small, secreted proteins associated with the maintenance of immune
homeostasis but also implicated with the pathogenesis of several autoimmune and …

Targeting signaling pathways with small molecules to treat autoimmune disorders

B Kaminska, K Swiatek-Machado - Expert Review of Clinical …, 2008 - Taylor & Francis
Chronic activation of immune responses, mediated by inflammatory mediators and involving
different effector cells of the innate and acquired immune system characterizes autoimmune …

Development of JAK inhibitors for the treatment of immune-mediated diseases: kinase-targeted inhibitors and pseudokinase-targeted inhibitors

HO Kim - Archives of Pharmacal Research, 2020 - Springer
JAKs are a family of intracellular tyrosine kinases consisting of four members, JAK1, JAK2,
JAK3, and TYK2. They are key components of the JAK-STAT pathway that transmit signals of …

Strategies to therapeutically modulate cytokine action

WJ Leonard, JX Lin - Nature Reviews Drug Discovery, 2023 - nature.com
Cytokines are secreted or membrane-presented molecules that mediate broad cellular
functions, including development, differentiation, growth and survival. Accordingly, the …

Can we design a better anti-cytokine therapy?

MS Drutskaya, GA Efimov, AA Kruglov… - Journal of Leukocyte …, 2017 - academic.oup.com
Cytokine neutralization is successfully used for treatment of various autoimmune diseases
and chronic inflammatory conditions. The complex biology of the two well-characterized …

Jak inhibitors for treatment of autoimmune diseases: Lessons from systemic sclerosis and systemic lupus erythematosus

P Kotyla, O Gumkowska-Sroka, B Wnuk, K Kotyla - Pharmaceuticals, 2022 - mdpi.com
Systemic sclerosis and systemic lupus erythematosus represent two distinct autoimmune
diseases belonging to the group of connective tissue disorders. Despite the great progress …

The emerging role of Janus kinase inhibitors in the treatment of autoimmune and inflammatory diseases

W Damsky, D Peterson, J Ramseier… - Journal of Allergy and …, 2021 - Elsevier
Autoimmune and inflammatory diseases are common and diverse, and they can affect
nearly any organ system. Much of the pathogenesis of these diseases is related to …

JAK inhibitors: Ten years after

FR Spinelli, F Meylan, JJ O'Shea… - European Journal of …, 2021 - Wiley Online Library
Abstract The European Journal of Immunology was launched 50 years ago, coinciding with
the discovery of many cytokines and growth factors and the emergence of an entirely new …

Emerging principles of cytokine pharmacology and therapeutics

RA Saxton, CR Glassman, KC Garcia - Nature Reviews Drug Discovery, 2023 - nature.com
Cytokines are secreted signalling proteins that play essential roles in the initiation,
maintenance and resolution of immune responses. Although the unique ability of cytokines …

Protein kinase inhibitors in the treatment of inflammatory and autoimmune diseases

H Patterson, R Nibbs, I McInnes… - Clinical & Experimental …, 2014 - academic.oup.com
Protein kinases mediate protein phosphorylation, which is a fundamental component of cell
signalling, with crucial roles in most signal transduction cascades: from controlling cell …